| Bioactivity | Onfasprodil is negative allosteric modulator of NR2B. Onfasprodil in combination with GABA receptor regulator has the potential for the research of Alzheimer's disease (extracted from patent CN111481543A)[1]. |
| Target | NR2B |
| Name | Onfasprodil |
| CAS | 1892581-29-1 |
| Formula | C20H23FN2O3 |
| Molar Mass | 358.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu, Shanglian, et al. Use of NR2B negative allosteric modulators in combination with GABA receptor modulators for the preparation of a medicament for the treatment of Alzheimer's disease. Patent CN111481543A. |
Onfasprodil
CAS: 1892581-29-1 F: C20H23FN2O3 W: 358.41
Onfasprodil is negative allosteric modulator of NR2B. Onfasprodil in combination with GABA receptor regulator has the po
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.